BENGALURU: Serum Institute of India, the largest in the world vaccine producer by volume, is close to signing a supply contract with the country. central government and it is likely to set prices at 250 rupees ($ 3.39) per dose of the vaccine, a business newspaper reported Tuesday, citing people familiar with the matter.
The government is pinning its massive supply hopes on the Serum Institute, which submitted the first formal application for approval of emergency use of AstraZenecaShot on Monday.
Executive Director Adar Poonawalla It had previously said that the vaccine would be priced at Rs 1,000 ($ 13.55) per dose in India’s private market, but governments that sign large supply deals would likely buy it at lower prices, Business Standard reports.
The government is pinning its massive supply hopes on the Serum Institute, which submitted the first formal application for approval of emergency use of AstraZenecaShot on Monday.
Executive Director Adar Poonawalla It had previously said that the vaccine would be priced at Rs 1,000 ($ 13.55) per dose in India’s private market, but governments that sign large supply deals would likely buy it at lower prices, Business Standard reports.
Poonawalla had said that Serum will focus first on supplying the vaccine to Indians before distributing it to other countries.
With 9.70 million Covid-19 cases recorded so far, India ranks second after the United States and is accelerating its review of vaccines developed by Pfizer Inc and AstraZeneca to authorize emergency use, a senior said Monday. official.
The Indian Council of Medical Research, the Serum Institute and the the Indian Ministry of Health he did not immediately respond to Reuters’ request for comment. ($ 1 = 73.8060 Indian rupees)
.
